Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to Immunotherapy-Reference-Cited by-同舟云学术

Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to Immunotherapy

Published:2021-11-05 Issue:3 Volume:28 Page:552-567
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Peng Shihong,Hu Pan,Xiao Yu-Tian^ORCID,Lu Weiqiang^ORCID,Guo Dandan,Hu Shixiu,Xie Jiayi,Wang Minna,Yu Weiwei,Yang Junjie^ORCID,Chen Huang,Zhang Xiaomin,Zhu Yasheng,Wang Ye,Yang Yue,Zhu Guanghui,Chen Sujun,Wang Jian,Zhang Bo,Chen Weidong,Wu Huangan,Sun Zhenliang,Ding Tao,Zhang Hankun,Yi Zhengfang,Liu Mingyao^ORCID,Ren Shancheng

Funder

National Key R&D Program of China

National Natural Science Foundation of China

Innovation program of Shanghai Municipal Education Commission

Fundamental Research Funds for the Central Universities, China Postdoctoral Science Foundation

Shanghai Municipal Commission of Science and Technology

Shenzhen Municipal Government of China

Science and Technology Commission Fund of Shanghai Fengxian District

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The implications for urological malignancies of non-coding RNAs in the the tumor microenvironment;Computational and Structural Biotechnology Journal;2024-12

2. Human intermediate prostate cancer stem cells contribute to the initiation and development of prostate adenocarcinoma;Stem Cell Research & Therapy;2024-09-11

3. MaskMol: Knowledge-guided Molecular Image Pre-Training Framework for Activity Cliffs with Pixel Masking;2024-09-09

4. Applications of single-cell technologies in drug discovery for tumor treatment;iScience;2024-08

5. Binding of interleukin-1 receptor antagonist to cholinergic receptor muscarinic 4 promotes immunosuppression and neuroendocrine differentiation in prostate cancer;Cancer Letters;2024-08